Linden Thomas Advisory Services LLC increased its holdings in shares of CorVel Co. (NASDAQ:CRVL – Free Report) by 9.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,940 shares of the business services provider’s stock after buying an additional 174 shares during the period. Linden Thomas Advisory Services LLC’s holdings in CorVel were worth $493,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently made changes to their positions in CRVL. GAMMA Investing LLC lifted its holdings in CorVel by 98.0% in the 2nd quarter. GAMMA Investing LLC now owns 97 shares of the business services provider’s stock valued at $25,000 after purchasing an additional 48 shares in the last quarter. Benjamin F. Edwards & Company Inc. raised its holdings in shares of CorVel by 474.2% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 178 shares of the business services provider’s stock worth $47,000 after acquiring an additional 147 shares during the period. Spire Wealth Management raised its holdings in shares of CorVel by 815.0% during the 1st quarter. Spire Wealth Management now owns 366 shares of the business services provider’s stock worth $96,000 after acquiring an additional 326 shares during the period. AXS Investments LLC purchased a new position in shares of CorVel during the 4th quarter worth $189,000. Finally, Vanguard Personalized Indexing Management LLC purchased a new position in shares of CorVel during the 4th quarter worth $264,000. Hedge funds and other institutional investors own 51.36% of the company’s stock.
CorVel Stock Performance
NASDAQ CRVL traded up $8.21 on Thursday, reaching $297.11. The stock had a trading volume of 12,716 shares, compared to its average volume of 37,603. CorVel Co. has a 12-month low of $187.92 and a 12-month high of $321.46. The business’s 50-day moving average price is $265.01 and its 200 day moving average price is $253.16. The stock has a market cap of $5.10 billion, a P/E ratio of 65.66 and a beta of 1.08.
Insiders Place Their Bets
In other news, Director Alan Hoops sold 1,700 shares of CorVel stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $300.00, for a total value of $510,000.00. Following the transaction, the director now directly owns 9,396 shares of the company’s stock, valued at approximately $2,818,800. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CFO Brandon O’brien sold 500 shares of CorVel stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $300.08, for a total value of $150,040.00. Following the completion of the transaction, the chief financial officer now owns 7,502 shares in the company, valued at approximately $2,251,200.16. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Alan Hoops sold 1,700 shares of CorVel stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $300.00, for a total value of $510,000.00. Following the completion of the transaction, the director now owns 9,396 shares of the company’s stock, valued at approximately $2,818,800. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 62,152 shares of company stock valued at $16,557,725. Insiders own 47.57% of the company’s stock.
Analysts Set New Price Targets
Separately, StockNews.com raised CorVel from a “hold” rating to a “buy” rating in a research report on Monday.
View Our Latest Report on CorVel
CorVel Profile
CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.
Further Reading
- Five stocks we like better than CorVel
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Owens-Corning Stock: Good Value or Recession Red Flag?
- Stock Sentiment Analysis: How it Works
- Datadog Exceeds Q2 Expectations, Solidifies Market Leadership
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Cybersecurity Stock Surges, Promising Double-Digit Gains
Want to see what other hedge funds are holding CRVL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CorVel Co. (NASDAQ:CRVL – Free Report).
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.